About PREPARED

Pandemic Preparedness Engaging Primary Care and Emergency Departments (PREPARED) is a multi-faceted initiative to help Canada prepare for future pandemics, by enhancing surveillance, improving care, creating a system to link patients to clinical trials, and to support the manufacturing of diagnostics, vaccines, and therapeutics.

Acute respiratory infections contribute significantly to the global disease burden, ranking as the third leading cause of mortality worldwide. Over two-thirds of all antibiotic prescriptions are for acute respiratory infections, despite the majority of these infections being viral in origin and therefore not requiring antibiotics. Patients infected with existing and novel pathogens are most likely to present first to primary care clinics and emergency departments, but access to the latest multi-pathogen point-of-care tests is limited. The ability to promptly diagnose and enroll patients into clinical trials for acute infections could substantially expedite research processes, lead to quicker validation of therapeutic strategies, and ultimately improve patient outcomes.

The purpose of this study is to:

  1. Enhance surveillance and bolster Canada’s ability to detect future pandemics
  2. Establish a system for referring eligible patients with acute infections to ongoing related clinical trials
  3. Provide rapid evidence to inform clinical and health system management and public health leaders, decision-makers, and planners within Canada and internationally

Frequently Asked Questions

Participants must have two of the specified respiratory symptoms, including:

  • runny nose
  • cough
  • fever
  • wheezing
  • sore throat
  • nasal congestion
  • shortness of breath
  • fatigue
  • rapid breathing
  • excessive mucus production
  • loss of smell or taste
  • presence of blood in your sputum
  • or trouble sleeping due to breathing difficulties

and be enrolled within 7 days of symptom onset

Participants must also be willing to undergo nasopharyngeal swabbing (swab used to collect nasal sample from back of the nose and/or throat).

If there are patients who are 50+ or 18-49 with 1 or more chronic medical condition(s) and/or immunosuppression, they would be considered high-risk and thus, would be approached for this study with a letter from their provider.

There are no medications being offered in this study.

The consent and swabbing would take about 30 minutes to complete.

Inserting a swab into the participant’s nostrils could cause a small discomfort or a brief sensation of pressure or tickling in their nose. The risks associated with swab tests are generally minimal. There is a small risk of causing minor nosebleeds or infection at the collection site. In rare cases, there might be a more severe reaction, such as injury to the nasal septum, but this is extremely uncommon.  There is a small risk of accidental release of identifiable information. Study staff will ensure that the identifiable information is kept secure.

If you have any questions, please contact prepared@unityhealth.to

Unity Health Toronto Research Ethics Board # 24-161

Sign up for PREPARED newsletter

Sign up for our newsletter for updates on our research study and job opportunities